Curtin University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Bentley Australia (1966)

Organization Overview

First Clinical Trial
2010
NCT02364583
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Curtin University | Curtin University of Technology

Active Ingredients

Drugs in Phase 4 Trials (2)

etoricoxib (Gencox) (1 trial)

primaquine (2 trials)

Drugs in Phase 3 Trials (5)

dihydroartemisinin (1 trial)

piperaquine (1 trial)

pyrimethamine (daraprim) (1 trial)

sulfadoxine (1 trial)

tafenoquine succinate (arakoda) (1 trial)

Drugs in Phase 2 Trials (2)

oxygen (1 trial)

pendulum wbf-038 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Arrest (Phase 2)

Hyperalgesia (Phase 4)

Malaria (Phase 4)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 9